Healthcare provider profile · identity verified

Beth Irene Esterbrook, M.D.

Internal Medicine · EPHRATA, PA · NPI 1437160736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	165
Levothyroxine Sodium	Levothyroxine Sodium	507	140
Amlodipine Besylate	Amlodipine Besylate	463	122
Omeprazole	Omeprazole	328	106
Lisinopril	Lisinopril	318	90
Metoprolol Succinate	Metoprolol Succinate	318	90
Furosemide	Furosemide	297	74
Losartan Potassium	Losartan Potassium	281	82
Simvastatin	Simvastatin	262	74
Pantoprazole Sodium	Pantoprazole Sodium	258	67
Gabapentin	Gabapentin	250	75
Rosuvastatin Calcium	Rosuvastatin Calcium	240	78
Sertraline Hcl	Sertraline Hcl	237	63
Eliquis	Apixaban	211	56
Hydrochlorothiazide	Hydrochlorothiazide	205	56
Potassium Chloride	Potassium Chloride	184	49
Lorazepam	Lorazepam	170	41
Metoprolol Tartrate	Metoprolol Tartrate	160	43
Tramadol Hcl	Tramadol Hcl	152	43
Metformin Hcl	Metformin Hcl	144	46
Tamsulosin Hcl	Tamsulosin Hcl	140	32
Famotidine	Famotidine	131	36
Albuterol Sulfate Hfa	Albuterol Sulfate	129	55
Metformin Hcl Er	Metformin Hcl	123	35
Clonazepam	Clonazepam	121	18
Clopidogrel	Clopidogrel Bisulfate	116	36
Trazodone Hcl	Trazodone Hcl	114	29
Zolpidem Tartrate	Zolpidem Tartrate	110	22
Citalopram Hbr	Citalopram Hydrobromide	103	31
Escitalopram Oxalate	Escitalopram Oxalate	93	24
Pravastatin Sodium	Pravastatin Sodium	93	23
Xarelto	Rivaroxaban	93	25
Alendronate Sodium	Alendronate Sodium	92	26
Donepezil Hcl	Donepezil Hcl	92	16
Glipizide Er	Glipizide	91	29
Duloxetine Hcl	Duloxetine Hcl	84	21
Montelukast Sodium	Montelukast Sodium	83	25
Carvedilol	Carvedilol	73	23
Synthroid	Levothyroxine Sodium	71	26
Fluticasone Propionate	Fluticasone Propionate	68	31
Jardiance	Empagliflozin	68	19
Spironolactone	Spironolactone	65	18
Quetiapine Fumarate	Quetiapine Fumarate	64	13
Valsartan	Valsartan	64	19
Finasteride	Finasteride	63	16
Allopurinol	Allopurinol	60	19
Atenolol	Atenolol	59	18
Ozempic	Semaglutide	57	15
Alprazolam	Alprazolam	56	17
Ezetimibe	Ezetimibe	55	16
Methylprednisolone	Methylprednisolone	55	50
Venlafaxine Hcl Er	Venlafaxine Hcl	55	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	16
Glipizide	Glipizide	53	15
Bupropion Xl	Bupropion Hcl	52	20
Prednisone	Prednisone	52	30
Buspirone Hcl	Buspirone Hcl	51	13
Celecoxib	Celecoxib	50	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	11
Glimepiride	Glimepiride	41	13
Oxycodone Hcl	Oxycodone Hcl	41	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Triamcinolone Acetonide	Triamcinolone Acetonide	40	24
Ondansetron Odt	Ondansetron	39	26
Pregabalin	Pregabalin	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Azelastine Hcl	Azelastine Hcl	36	13
Azithromycin	Azithromycin	36	36
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	13
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Torsemide	Torsemide	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Meloxicam	Meloxicam	33	11
Lovastatin	Lovastatin	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Januvia	Sitagliptin Phosphate	31	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Linzess	Linaclotide	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Nystatin	Nystatin	30	21
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Cephalexin	Cephalexin	29	20
Benazepril Hcl	Benazepril Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	23
Sucralfate	Sucralfate	23	suppressed
Amoxicillin	Amoxicillin	22	15
Fluconazole	Fluconazole	22	18
Mirtazapine	Mirtazapine	22	suppressed
Baclofen	Baclofen	20	suppressed
Clotrimazole	Clotrimazole	20	14
Divalproex Sodium	Divalproex Sodium	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Fenofibrate	Fenofibrate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Novolog Flexpen	Insulin Aspart	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Estradiol	Estradiol	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ssd	Silver Sulfadiazine	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Euthyrox	Levothyroxine Sodium	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error